Filtered By:
Condition: Parkinson's Disease
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 2135 results found since Jan 2013.
Four New Updates in Stroke and Parkinson Disease Four New Updates in Stroke and Parkinson Disease
Dr Hans-Christoph Diener presents four new neurology studies, two in stroke and two in Parkinson ' s.Medscape Neurology
Source: Medscape Today Headlines - December 6, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news
Prediction of Falls in Subjects Suffering From Parkinson Disease, Multiple Sclerosis, and Stroke: Methodologic Issues
I was interested to read the article by Beghi et al1 published in the April 2018 issue of Archives. The authors aimed to compare the risk of falls and fall predictors in patients with Parkinson disease (PD), multiple sclerosis (MS), and stroke. They included a total of 299 patients as follows: PD (n=94), MS (n=111), and stroke (n=94). They appli ed functional scales to investigate balance, disability, daily performance, self-confidence with balance, and social integration. Patients were followed for 6 months.
Source: Archives of Physical Medicine and Rehabilitation - July 25, 2018 Category: Rehabilitation Authors: Siamak Sabour Tags: Departments Source Type: research
Patient-Tailored Augmented Reality Games for Assessing Upper Extremity Motor Impairments in Parkinson ’s Disease and Stroke
In this study, we explore the potential of AR for evaluating 1) speed and goal-directedness of movements within the individually determined interaction space, 2) adaptation of hand opening to objects of different sizes, and 3) obstacle avoidance in healthy individuals (N = 10) and two highly prevalent neurological conditions (N = 10 patients with Parkinson’s Disease andN = 10 stroke patients). We successfully implemented three AR games to evaluate these key aspects of motor function. As expected, PD patients moved slower than controls and needed more time for task completion. No differences were observed betw...
Source: Journal of Medical Systems - October 30, 2018 Category: Information Technology Source Type: research
Is Incorrect Anti-Coagulation Dosing Contributing to Ischaemic Stroke Burden? A Retrospective Single-Centre Study from Regional New South Wales, Australia
Background: Atrial fibrillation (AF) contributes to 30% of ischaemic stroke presentations. Low doses of anti-coagulants are often prescribed to prevent stroke but ameliorate bleeding risk.
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: P. Bamford, M. Ray, S. Cheruvu, M. Parkinson, C. Said, J. Trappel, J. Rogers Tags: 195 Source Type: research
Retraction notice to “Efficacy of Bisphosphonates against Hip Fracture in Elderly Patients with Stroke and Parkinson Diseases: Meta-analysis of Randomized Controlled Trials” Journal of Stroke and Cerebrovascular Diseases, Vol. 23, No. 10 (November-December), 2014: pp 2714-2724
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
Source: Journal of Stroke and Cerebrovascular Diseases - March 6, 2021 Category: Neurology Authors: Weiwei Zhang, Chen Zhu, Mengwen Sun, Yuhao Ge, Guang Yan Tags: Retraction Source Type: research
The therapeutic benefits of intravenously administrated nanoparticles in stroke and age-related neurodegenerative diseases
Curr Pharm Des. 2022 Jun 8. doi: 10.2174/1381612828666220608093639. Online ahead of print.ABSTRACTThe mean global lifetime risk of neurological disorders such as stroke, Alzheimer's disease (AD), and Parkinson's disease (PD) has shown a large effect on economy and society.Researchersare stillstruggling to find effective drugs to treatneurological disordersand drug delivery through the blood-brain barrier (BBB) is a major challenge to be overcome. The BBB is a specialized multicellular barrier between the peripheral blood circulation and the neural tissue. Unique and selective features of the BBB allow it to tightly control...
Source: Current Pharmaceutical Design - June 9, 2022 Category: Drugs & Pharmacology Authors: Mehdi Farhoudi Saeed Sadigh-Eteghad Javad Mahmoudi Afsaneh Farjami Afsaneh Farjami Mohammad Mahmoudian Sara Salatin Source Type: research
Evaluation of extrapyramidal diseases with Parkinson ’s disease in patients suffering from stroke in Tashkent region, Uzbekistan
Background:Much attention has appealed to the frequency of stroke and neurodegenerative diseases correlated with the age of the patient. To determine the incidence and clinical characteristics of PD in patients with stroke.
Source: Parkinsonism and Related Disorders - August 1, 2023 Category: Neurology Authors: J. Sabirov, U. Azamat, R. Yuldashev Source Type: research
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy
Fatigue is commonly reported in many neurologic illnesses, including multiple sclerosis, Parkinson disease, myasthenia gravis, traumatic brain injury, and stroke. Fatigue contributes substantially to decrements in quality of life and disability in these illnesses. Despite the clear impact of fatigue as a disabling symptom, our understanding of fatigue pathophysiology is limited and current treatment options rarely lead to meaningful improvements in fatigue. Progress continues to be hampered by issues related to terminology and assessment. In this article, we propose a unified taxonomy and a novel assessment approach to add...
Source: Neurology - January 21, 2013 Category: Neurology Authors: Kluger, B. M., Krupp, L. B., Enoka, R. M. Tags: All Clinical Neurology, Parkinson's disease/Parkinsonism, All Cerebrovascular disease/Stroke, Multiple sclerosis VIEWS & amp;amp; REVIEWS Source Type: research
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy
ABSTRACT
Autopsy is the diagnostic gold standard for progressive supranuclear palsy (PSP). The National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy (NINDS‐SPSP) criteria for the clinical diagnosis of “probable” PSP are thought to possess high specificity and low sensitivity. The NINDS‐SPSP criteria for “possible” PSP are considered to increase sensitivity at the expense of specificity. The Neuroprotection and Natural History in Parkinson Plus Syndromes (NNIPPS) criteria are intended to improve sensitivity while maintaining high specificity. The aim of this study...
Source: Movement Disorders - January 1, 2013 Category: Neurology Authors: Gesine Respondek, Sigrun Roeber, Hans Kretzschmar, Claire Troakes, Safa Al‐Sarraj, Ellen Gelpi, Carles Gaig, Wang Zheng Chiu, John C. Swieten, Wolfgang H. Oertel, Günter U. Höglinger Tags: Research Article Source Type: research
Neuropsychologic assessment in collaborative Parkinson’s disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson’s Disease Research at the University of Pennsylvania and the University of Washington
Abstract: Cognitive impairment (CI) and behavioral disturbances can be the earliest symptoms of Parkinson's disease (PD), ultimately afflict the vast majority of PD patients, and increase caregiver burden. Our two Morris K. Udall Centers of Excellence for Parkinson's Disease Research were supported by the National Institute of Neurological Disorders and Stroke (NINDS) in an effort to recommend a comprehensive yet practical approach to cognitive and behavioral assessment to further collaborative research. We recommend a stepwise approach with two levels of standardized evaluation to establish a common battery, as well as an...
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - November 19, 2012 Category: Geriatrics Authors: G. Stennis Watson, Brenna A. Cholerton, Rachel G. Gross, Daniel Weintraub, Cyrus P. Zabetian, John Q. Trojanowski, Thomas J. Montine, Andrew Siderowf, James B. Leverenz Tags: Perspectives Source Type: research
